CLINICAL_TRIALS
trial_result
· 2012-09-12
Clinical Trial Update: Aprepitant in the Management of Biological Therapies-related Severe Pruritus [Phase 2]
Summary
Phase 2 trial evaluating aprepitant for management of severe pruritus related to biological therapies; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Campus Bio-Medico University | Conditions: ITCH | Phase 2 | Status: COMPLETED